Navigation Links
One-Year European Registry Data Released for Popliteal Stenting With SUPERA®
Date:2/8/2011

LEIPZIG, Germany, Feb. 8, 2011 /PRNewswire/ -- Data from the Leipzig Registry tracking the results of patients treated with the SUPERA® stent for peripheral arterial disease (PAD) of the popliteal artery were reported during the recent 2011 Leipzig Interventional Course (LINC).  The SUPERA stent is CE marked for biliary and peripheral vascular use in Europe.  In the United States the SUPERA stent is the subject of an ongoing FDA-approved IDE trial called SUPERB (Comparison of the SUPERA PERipheral System to a Performance Goal Derived from Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery) for treatment of PAD of the superficial femoral artery (SFA).

Dr. Andrej Schmidt of the Department of Angiology at Park Hospital and Heart Center in Leipzig presented the 12-month European data.  The 101 patients treated at Park Hospital had advanced PAD.  Nearly a third of the patients were classified as Rutherford 4 or 5, and almost 50 percent had an occlusion of the popliteal artery.  The average stent length within the registry was approximately 8.5 centimeters.

The primary patency rate, measured by duplex ultrasonography, was 87 percent at 12 months.  In addition, there were no stent fractures detected by x-ray at an average of 13.3 months.

"The SUPERA stent has become our stent of choice," commented Dr. Schmidt.  "No standard nitinol stent provides the same level of flexibility and radial strength, and both characteristics are necessary to conform to and support the SFA and popliteal anatomy."

"SUPERA is a different class of stent, and is exhibiting remarkable long-term durability in extremely diseased patients," commented Richard C. Kovach, M.D. and Chair, Department of Endovascular Medicine and Director, Cardiac Catheterization Laboratory at Deborah Heart and Lung Center in Browns Mills, New Jersey.  "There were several presentations and live cases throughout LINC highlighting ho
'/>"/>

SOURCE IDEV Technologies, Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
2. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
4. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
5. New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease
6. Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary
7. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
10. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
11. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is ... introduction of the first-of-its-kind comic book available in ... has been designed specifically to educate children and their parents ... Canada affecting more than 300,000 Canadians. Eisai is ... care (hhc) , in which the patient is central – ...
(Date:8/21/2014)... CHARLOTTE, N.C. , Aug. 21, 2014 /PRNewswire-iReach/ ... Home Medical Equipment, Inc. for the third straight ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... important treatment option for more vulnerable populations , ... showed that pitavastatin is an effective treatment for the ... safety and tolerability profile to low-dose pravastatin. The ... the XV International Symposium on Atherosclerosis in Boston. , ...
... was found to be prevalent in cancer patients regardless of ... conducted at Cancer Treatment Centers of America ... screening for vitamin D deficiency and aggressive vitamin D repletion ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO ) , ...
Cached Medicine Technology:Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 2Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 3Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients 2
(Date:8/22/2014)... growth factor receptor (EGFR) mutations found in the circulating ... non-small cell lung cancer (NSCLC) patients correlates well with ... EGFR tyrosine kinase inhibitor (TKI) therapy is approved for ... the standard for determining mutation status is with DNA ... or not available. A more abundant and less invasive ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 ... Dr. Sen and Dr. Samantha Pearson to help people ... and avoid corrective vision surgery by instead improving their ... prompting an investigative review. , “There’s a reason ... dollars in revenue each year—it’s because people just assume ...
(Date:8/22/2014)... Chicago, IL (PRWEB) August 22, 2014 ... become a thriving fertility destination, and now offers the ... interdisciplinary team of infertility specialists. The fertility network of ... an overall commitment to world-class reproductive care, female and ... program lives up to the standards so eminently set ...
(Date:8/22/2014)... August 22, 2014 The improved access ... specifically in the developing world, has led to the ... number of deaths due to AIDS globally. However, despite ... number of new patients becoming affected by the virus ... being undertaken by all related organisations and stakeholders, by ...
(Date:8/22/2014)... August 22, 2014. A new study of ... with multiple sclerosis (MS) may be able to ... study was epublished ahead of print on July ... Genova, Hali Griswold, Nancy D. Chiaravalloti & John ... with multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one,s ...
Breaking Medicine News(10 mins):Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... Reinberg HealthDay Reporter , TUESDAY, Feb. 7 (HealthDay News) ... a new "universal" influenza vaccine: one that might be effective against ... year, as now happens. "Our hope is to develop a ... subtypes so we won,t need to keep making new flu vaccines ...
... Repeat cases of shingles may be more common than suspected, ... people only get shingles once in a lifetime. People ... severe pain. The condition is caused by the herpes zoster ... Minn., analyzed the medical records of nearly 1,700 patients, aged ...
... Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly (STMS) publishing ... 42 new titles to its journals program in 2011, ... collaboration with societies or other organizations. Beginning ... Wiley Online Library, offering the latest, peer-reviewed research in ...
... a new and unusual "app" for the smart phone: tracking air ... and preventive medicine, has received a grant to assess a person,s ... this case, the City of Buffalo. The study is ... Health (NIH). A city,s air pollution varies from downtown ...
... associated with higher risks of obesity, heart disease, diabetes, and ... In a ground-breaking new study published in the Feb. ... from University Hospitals (UH) Case Medical Center and Case Western ... less than six hours of sleep at night had an ...
... Mich. Without fanfare, hundreds of thousands of children ... usually to alleviate recurring infections and obstructive sleep problems. ... to a pathologist, who looks for evidence of more ... common practice may not be cost-effective because those additional ...
Cached Medicine News:Health News:'Universal' Flu Vaccine Shows Promise in Early Trial 2Health News:'Universal' Flu Vaccine Shows Promise in Early Trial 3Health News:Shingles Returns More Often Than Thought 2Health News:Over 40 new titles added to Wiley-Blackwell's journals program in 2011 2Health News:New study to use smart phones to track air pollution exposure 2Health News:Lack of sleep found to be a new risk factor for colon cancer 2Health News:The great tonsil dilemma 2Health News:The great tonsil dilemma 3
Solid 4 mm blades. Locking thumb. Dull finish. Holes in bar decrease weight of speculum....
Open 14 mm blades with 6 mm lifting wings. Dull finish....
Open 10 mm blades. Dull finish....
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Medicine Products: